Proteomic analysis of formalin-fixed paraffin-embedded pancreatic tissue using liquid chromatography tandem mass spectrometry

Pancreas

Volumn 41, Issue 2, 2012, Pages 175-185

  Paulo, Joao A ^a,b   Lee, Linda S ^b   Banks, Peter A ^b   Steen, Hanno ^a,c   Conwell, Darwin L ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

biomarker; chronic pancreatitis; FFPE; pancreas; pancreas tissue; pancreatic cancer

Indexed keywords

ANNEXIN; COLLAGEN; FIBRONECTIN; FILAMIN A; FORMALDEHYDE; PANCREAS ENZYME; PARAFFIN; PROTEIN; RETINOL DEHYDROGENASE;

ARTICLE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; PANCREAS; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TANDEM MASS SPECTROMETRY;

BIOLOGICAL MARKERS; BOSTON; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; COMPUTATIONAL BIOLOGY; FIXATIVES; FORMALDEHYDE; HUMANS; PANCREAS; PANCREATIC NEOPLASMS; PANCREATITIS, CHRONIC; PARAFFIN EMBEDDING; PROTEINS; PROTEOMICS; TANDEM MASS SPECTROMETRY; TISSUE FIXATION;

EID: 84857917059     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e318227a6b7     Document Type: Article

References (81)

1. NIH. Opportunities and Challenges in Digestive Diseases Research: Recommendations of the National Commission on Digestive Diseases. US Department of Health and Human Services, National Institutes of Health; 2009. Publication no. 08-6514:159-167.
2. Thongboonkerd V. Proteomics of Human Body Fluids: Principles, Methods, and Applications. Totowa, NJ: Humana Press; 2007.
3. Decramer S, Gonzalez de Peredo A, Breuil B, et al. Urine in clinical proteomics. Mol Cell Proteomics. 2008;7:1850-1862.
4. Good DM, Thongboonkerd V, Novak J, et al. Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. J Proteome Res. 2007;6:4549-4555.
5. Paik YK, Kim H, Lee EY, et al. Overview and introduction to clinical proteomics. Methods Mol Biol. 2008;428:1-31. (Pubitemid 351365932)
6. Barratt J, Topham P. Urine proteomics: the present and future of measuring urinary protein components in disease. CMAJ. 2007;177:361-368. (Pubitemid 47339533)
7. Hortin GL, Sviridov D. Diagnostic potential for urinary proteomics. Pharmacogenomics. 2007;8:237-255. (Pubitemid 46477735)
8. Muller H, Brenner H. Urine markers as possible tools for prostate cancer screening: review of performance characteristics and practicality. Clin Chem. 2006;52:562-573.
9. Munro NP, Cairns DA, Clarke P, et al. Urinary biomarker profiling in transitional cell carcinoma. Int J Cancer. 2006;119:2642-2650. (Pubitemid 44691320)
10. Thongboonkerd V. Urinary proteomics: towards biomarker discovery, diagnostics and prognostics. Mol Biosyst. 2008;4:810-815. (Pubitemid 352009217)
11. Paulo JA, Lee LS, Wu B, et al. Cytokine profiling of pancreatic fluid using the ePFT collection method in tandem with a multiplexed microarray assay. J Immunol Methods. 2011;369:98-107.
12. Tammen H. Specimen collection and handling: standardization of blood sample collection. Methods Mol Biol. 2008;428:35-42.
13. Shi SR, Cote RJ, Taylor CR. Antigen retrieval techniques: current perspectives. J Histochem Cytochem. 2001;49:931-937. (Pubitemid 32675000)
14. Steen H, Mann M. The ABC's (and XYZ's) of peptide sequencing. Nat Rev Mol Cell Biol. 2004;5:699-711.
15. Reimel BA, Pan S, May DH, et al. Proteomics on fixed tissue specimensVa review. Curr Proteomics. 2009;6:63-69.
16. Cheung W, Darfler MM, Alvarez H, et al. Application of a global proteomic approach to archival precursor lesions: deleted in malignant brain tumors 1 and tissue transglutaminase 2 are upregulated in pancreatic cancer precursors. Pancreatology. 2008;8:608-616.
17. Balgley BM, Guo T, Zhao K, et al. Evaluation of archival time on shotgun proteomics of formalin-fixed and paraffin-embedded tissues. J Proteome Res. 2009;8:917-925.
18. Jiang X, Feng S, Tian R, et al. Development of efficient protein extraction methods for shotgun proteome analysis of formalin-fixed tissues. J Proteome Res. 2007;6:1038-1047. (Pubitemid 46480468)
19. Palmer-Toy DE, Krastins B, Sarracino DA, et al. Efficient method for the proteomic analysis of fixed and embedded tissues. J Proteome Res. 2005;4:2404-2411. (Pubitemid 41814314)
20. Xu H, Yang L, Wang W, et al. Antigen retrieval for proteomic characterization of formalin-fixed and paraffin-embedded tissues. J Proteome Res. 2008;7:1098-1108.
21. Shilov IV, Seymour SL, Patel AA, et al. The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol Cell Proteomics. 2007;6:1638-1655. (Pubitemid 47506173)
22. Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25:25-29. (Pubitemid 30257031)
23. Li D, Li JQ, Ouyang SG, et al. An integrated strategy for functional analysis in large-scale proteomic research by gene ontology. Progr Biochem Biophys. 2005;32:1026-1029. (Pubitemid 43128721)
24. Dong L, Jianqi L, Shuguang O, et al. An integrated strategy for functional analysis in large scale proteomic research by gene ontology. Mol Cell Proteomics. 2005;4:S34-S34.
25. Bairoch A, Apweiler R, Wu CH, et al. The Universal Protein Resource (UniProt). Nucl Acids Res. 2005;33:D154-D159.
26. Dennis G Jr, Sherman BT, Hosack DA, et al. Database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4:P3.
27. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44-57.
28. Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000;28:27-30. (Pubitemid 30047706)
29. Ogata H, Goto S, Sato K, et al. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 1999;27:29-34. (Pubitemid 29209394)
30. Wixon J, Kell D. The Kyoto Encyclopedia of Genes and GenomesVKEGG. Yeast. 2000;17:48-55.
31. Hood BL, Darfler MM, Guiel TG, et al. Proteomic analysis of formalin-fixed prostate cancer tissue. Mol Cell Proteomics. 2005;4:1741-1753. (Pubitemid 41749267)
32. Ostasiewicz P, Zielinska DF, Mann M, et al. Proteome, phosphoproteome, and N-glycoproteome are quantitatively preserved in formalin-fixed paraffin-embedded tissue and analyzable by high-resolution mass spectrometry. J Proteome Res. 2010;9:3688-3700.
33. Guo T,WangW, Rudnick PA, et al. Proteome analysis of microdissected formalin-fixed and paraffin-embedded tissue specimens. J Histochem Cytochem. 2007;55:763-772. (Pubitemid 46981773)
34. Shi SR, Liu C, Balgley BM, et al. Protein extraction from formalin-fixed, paraffin-embedded tissue sections: quality evaluation by mass spectrometry. J Histochem Cytochem. 2006;54:739-743. (Pubitemid 43736896)
35. Waanders LF, Chwalek K, Monetti M, et al. Quantitative proteomic analysis of single pancreatic islets. Proc Natl Acad Sci U S A. 2009;106:18902-18907.
36. Crockett DK, Lin Z, Vaughn CP, et al. Identification of proteins from formalin-fixed paraffin-embedded cells by LC-MS/MS. Lab Invest. 2005;85:1405-1415. (Pubitemid 41509388)
37. Beck IT. The role of pancreatic enzymes in digestion. Am J Clin Nutr. 1973;26:311-325.
38. Gagnon I, Duester G, Bhat PV. Enzymatic characterization of recombinant mouse retinal dehydrogenase type 1. Biochem Pharmacol. 2003;65:1685-1690. (Pubitemid 36577281)
39. Madro A, Celinski K, Slomka M. The role of pancreatic stellate cells and cytokines in the development of chronic pancreatitis. Med Sci Monit. 2004;10:RA166-RA170. (Pubitemid 38988186)
40. Kereszturi E, Kiraly O, Sahin-Toth M. Minigene analysis of intronic variants in common SPINK1 haplotypes associated with chronic pancreatitis. Gut. 2009;58:545-549.
41. Hucl T, Jesnowski R, Pfutzer RH, et al. SPINK1 variants in young-onset pancreatic cancer. J Gastroenterol. 2007;42:599. (Pubitemid 47190081)
42. Keim V. Mutations of the SPINK1 gene and their relation to chronic pancreatitis. Pancreatology. 2005;5:311. (Pubitemid 41160264)
43. Matsubayashi H, Fukushima N, Sato N, et al. Polymorphisms of SPINK1 N34S and CFTR in patients with sporadic and familial pancreatic cancer. Cancer Biol Ther. 2003;2:652-655.
44. Li C, Yu S, Nakamura F, et al. Binding of pro-prion to filamin A disrupts cytoskeleton and correlates with poor prognosis in pancreatic cancer. J Clin Invest. 2009;119:2725-2736.
45. Geng LY, Shi ZZ, Dong Q, et al. Expression of SNC73, a transcript of the immunoglobulin alpha-1 gene, in human epithelial carcinomas. World J Gastroenterol. 2007;13:2305-2311. (Pubitemid 46860730)
46. Mews P, Phillips P, Fahmy R, et al. Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis. Gut. 2002;50:535-541. (Pubitemid 34638875)
47. Masamune A, Watanabe T, Kikuta K, et al. Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis. Clin Gastroenterol Hepatol. 2009;7:S48-S54.
48. Sitek B, Sipos B, Alkatout I, et al. Analysis of the Pancreatic Tumor Progression by a Quantitative Proteomic Approach and Immunhistochemical Validation. J Proteome Res. 2009;8:1647-1656.
49. Shen J, Person MD, Zhu J, et al. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res. 2004;64:9018-9026. (Pubitemid 39665512)
50. Fukuoka S, Kern H, Kazuki-Sugino R, et al. Cloning and characterization of ZAP36, an annexin-like, zymogen granule membrane associated protein, in exocrine pancreas. Biochim Biophys Acta. 2002;1575:148-152. (Pubitemid 34521789)
51. Yi M, Ruoslahti E. A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis. Proc Natl Acad Sci U S A. 2001;98:620-624. (Pubitemid 32105092)
52. Schwarz RE, Awasthi N, Konduri S, et al. Antitumor effects of EMAP II against pancreatic cancer through inhibition of fibronectin-dependent proliferation. Cancer Biol Ther. 2010;9:632-639.
53. Cui Y, Zhang D, Jia Q, et al. Proteomic and tissue array profiling identifies elevated hypoxia-regulated proteins in pancreatic ductal adenocarcinoma. Cancer Invest. 2009;27:747-755.
54. Mulla A, Christian HC, Solito E, et al. Expression, subcellular localization and phosphorylation status of annexins 1 and 5 in human pituitary adenomas and a growth hormone-secreting carcinoma. Clin Endocrinol (Oxf). 2004;60:107-119. (Pubitemid 38183506)
55. Iacobuzio-Donahue CA, Maitra A, Olsen M, et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol. 2003;162:1151-1162. (Pubitemid 36350660)
56. Chatzizacharias NA, Giaginis C, Zizi-Serbetzoglou D, et al. Evaluation of the clinical significance of focal adhesion kinase and SRC expression in human pancreatic ductal adenocarcinoma. Pancreas. 2010;39(6):930-936.
57. Duxbury MS, Ito H, Ashley SW, et al. CEACAM6 cross-linking induces caveolin-1-dependent, Src-mediated focal adhesion kinase phosphorylation in BxPC3 pancreatic adenocarcinoma cells. J Biol Chem. 2004;279:23176-23182. (Pubitemid 38685623)
58. Duxbury MS, Ito H, Benoit E, et al. RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity. Biochem Biophys Res Commun. 2003;311:786-792. (Pubitemid 37377726)
59. Furuyama K, Doi R, Mori T, et al. Clinical significance of focal adhesion kinase in resectable pancreatic cancer. World J Surg. 2006;30:219-226. (Pubitemid 43162494)
60. Kiehne K, Herzig KH, Folsch UR. Regulation of the actin cytoskeleton by p125 focal adhesion kinase in rat pancreatic acinar cells. Digestion 1999;60:153-160. (Pubitemid 29142030)
61. Rait VK, Xu L, O'Leary TJ, et al. Modeling formalin fixation and antigen retrieval with bovine pancreatic RNase A II. Interrelationship of cross-linking, immunoreactivity, and heat treatment. Lab Invest. 2004;84:300-306. (Pubitemid 41656485)
62. Rait VK, O'Leary TJ, Mason JT. Modeling formalin fixation and antigen retrieval with bovine pancreatic ribonuclease A: I-structural and functional alterations. Lab Invest. 2004;84:292-299. (Pubitemid 41656484)
63. Fox CH, Johnson FB, Whiting J, et al. Formaldehyde fixation. J Histochem Cytochem. 1985;33:845-853.
64. Ahram M, Flaig MJ, Gillespie JW, et al. Evaluation of ethanol-fixed, paraffin-embedded tissues for proteomic applications. Proteomics. 2003;3:413-421. (Pubitemid 36428294)
65. Romero RL, Juston AC, Ballantyne J, et al. The applicability of formalin-fixed and formalin fixed paraffin embedded tissues in forensic DNA analysis. J Forensic Sci. 1997;42:708-714. (Pubitemid 27348970)
66. Benchekroun M, DeGraw J, Gao J, et al. Impact of fixative on recovery of mRNA from paraffin-embedded tissue. Diagn Mol Pathol. 2004;13:116-125. (Pubitemid 38668147)
67. McKenna RJ Jr, Houck WV. New approaches to the minimally invasive treatment of lung cancer. Curr Opin Pulm Med. 2005;11:282-286. (Pubitemid 41073149)
68. Becker KF, Schott C, Hipp S, et al. Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis. The Journal of Pathology. 2007;211:370-378. (Pubitemid 46172713)
69. Paulo J, Lee LS, Banks PA, et al. Proteomic analysis of endoscopically (ePFT) collected gastroduodenal fluid using in-gel tryptic digestion followed by liquid chromatography-tandem mass spectrometry. Proteomics - Clinical Applications 2010;4:715-725.
70. Paulo JA, Lee LS, Wu B, et al. Identification of Pancreas-Specific Proteins in Endoscopically (Endoscopic Pancreatic Function Test) Collected Pancreatic Fluid with Liquid Chromatography- Tandem Mass Spectrometry. Pancreas. 2010;39:889-896.
71. Grantzdorffer I, Yumlu S, Gioeva Z, et al. Comparison of different tissue sampling methods for protein extraction from formalin-fixed and paraffin-embedded tissue specimens. Exp Mol Pathol. 2010;88:190-196.
72. Scicchitano MS, Dalmas DA, Boyce RW, et al. Protein extraction of formalin-fixed, paraffin-embedded tissue enables robust proteomic profiles by mass spectrometry. J Histochem Cytochem. 2009;57:849-860.
73. Fritz JS, Gjerde DT. Ion Chromatography. New York, NY: Wiley-VCH; 2000.
74. Wisniewski JR, Zougman A, Mann M. Combination of FASP and StageTip-based fractionation allows in-depth analysis of the hippocampal membrane proteome. J Proteome Res. 2009;8:5674-5678.
75. Wisniewski JR, Zougman A, Nagaraj N, et al. Universal sample preparation method for proteome analysis. Nat Methods. 2009;6:359-362.
76. Emmert-Buck MR, Bonner RF, Smith PD, et al. Laser capture microdissection. Science. 1996;274:998-1001. (Pubitemid 26398425)
77. Patel V, Hood BL, Molinolo AA, et al. Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression. Clin Cancer Res. 2008;14:1002-1014. (Pubitemid 351302545)
78. Nonn L, Vaishnav A, Gallagher L, et al. mRNA and micro-RNA expression analysis in laser-capture microdissected prostate biopsies: valuable tool for risk assessment and prevention trials. Exp Mol Pathol. 2010;88:45-51.
79. Ikenaga N, Ohuchida K, Mizumoto K, et al. S100A4 mRNA is a diagnostic and prognostic marker in pancreatic carcinoma. J Gastrointest Surg. 2009;13:1852-1858.
80. Liu A, Tetzlaff MT, Vanbelle P, et al. MicroRNA expression profiling outperforms mRNA expression profiling in formalin-fixed paraffin-embedded tissues. Int J Clin Exp Pathol. 2009;2:519-527.
81. Gjerdrum LM, Abrahamsen HN, Villegas B, et al. The influence of immunohistochemistry on mRNA recovery from microdissected frozen and formalin-fixed, paraffin-embedded sections. Diagn Mol Pathol. 2004;13:224-233. (Pubitemid 39552244)